As of March 2026 Immunovant has a market cap of โน471.73 Billion. This makes Immunovant the world's 3010th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
On Mar 16th, 2026 the market cap of Immunovant was reported to be: